Neuromuscular blockade (NMB) agents were tested to see if they could lower lactate levels and improve outcomes in comatose patients after cardiac arrest.
A study involving 83 patients compared the effects of continuous NMB for 24 hours against usual care, measuring changes in lactate levels and survival rates.
The results showed no significant difference in lactate reduction, overall survival, or good functional outcomes between the two groups.